ArticleViruses2024

Evaluation of a Commercial Rapid Molecular Point-of-Care Assay for Differential Diagnosis Between SARS-CoV-2 and Flu A/B Infections in a Pediatric Setting.

Paolo Bottino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.